In coronary artery disease, the transition from an apparently stable state to a life-threatening acute cardiac event is difficult to predict. As such, a recent study applied proteomic and metabolomic approaches to discover new biomarkers that signal imminent myocardial infarction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ross, R. N. Engl. J. Med. 340, 115–126 (1999).
Gustafsson, S. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00422-2 (2024).
Lowry, M. T. H. et al. Eur. Heart. J. 44, 2846–2858 (2023).
Di Angelantonio, E. et al. Circulation 120, 2177–2187 (2009).
de Bakker, M. et al. Circulation 147, 1798–1808 (2023).
Gürgöze, M. T. et al. Eur. Heart J. Acute Cardiovasc. Care 12, 451–461 (2023).
West, N. E. J. et al. JACC Basic Transl. Sci. 2, 646–654 (2017).
American Diabetes Association. Diabetes Care 46, S111–S127 (2023).
Parolo, C. et al. ACS Sens. 5, 1877–1881 (2020).
Welsh, P. et al. Clin. Chem. https://doi.org/10.1093/clinchem/hvad205 (2023).
Acknowledgements
D.M.K. is supported by a British Heart Foundation Intermediate Basic Science Research Fellowship (FS/IBSRF/23/25161). N.L.M. is supported by a Chair Award (CH/F/21/90010), Programme Grant (RG/20/10/34966) and a Research Excellent Award (RE/18/5/34216) from the British Heart Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
N.L.M. reports receiving research grants awarded to the University of Edinburgh from Abbott Diagnostics, Siemens Healthineers and Roche Diagnostics unrelated to this work, and honoraria from Abbott Diagnostics, Siemens Healthineers, Roche Diagnostics, LumiraDx and Psyros Diagnostics.
Rights and permissions
About this article
Cite this article
de Bakker, M., Kimenai, D.M. & Mills, N.L. Challenges and opportunities for biomarker discovery to predict imminent myocardial infarction. Nat Cardiovasc Res 3, 102–103 (2024). https://doi.org/10.1038/s44161-024-00424-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-024-00424-0